Statins and hepatotoxicity : Focus on patients with fatty liver von CHALASANI, Naga

Volltext

Randomised clinical study: GR‐MD‐02, a galectin‐3 inhibitor, vs. placebo in patients having non‐alcoholic steatohepatitis with advanced fibrosis von Harrison, S. A., Marri, S. R., Chalasani, N., Kohli, R., Aronstein, W., Thompson, G. A., Irish, W., Miles, M. V., Xanthakos, S. A., Lawitz, E., Noureddin, M., Schiano, T. D., Siddiqui, M., Sanyal, A., Neuschwander‐Tetri, B. A., Traber, P. G.

Volltext

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non‐HDL‐C levels von Corey, K. E., Vuppalanchi, R., Wilson, L. A., Cummings, O. W., Chalasani, N.

Volltext

Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease von Chalasani, N., Vuppalanchi, R., Rinella, M., Middleton, M. S., Siddiqui, M. S., Barritt, A. S., Kolterman, O., Flores, O., Alonso, C., Iruarrizaga‐Lejarreta, M., Gil‐Redondo, R., Sirlin, C. B., Zemel, M. B.

Volltext

Editorial: treating the liver to treat the kidney in non‐alcoholic steatohepatitis – authors' reply von Vilar‐Gomez, E., Chalasani, N.

Volltext

Serum proteomic profiling in patients with drug-induced liver injury von Bell, L. N., Vuppalanchi, R., Watkins, P. B., Bonkovsky, H. L., Serrano, J., Fontana, R. J., Wang, M., Rochon, J., Chalasani, N.

Volltext

Duloxetine hepatotoxicity: a case‐series from the drug‐induced liver injury network von Vuppalanchi, R., Hayashi, P. H., Chalasani, N., Fontana, R. J., Bonkovsky, H., Saxena, R., Kleiner, D., Hoofnagle, J. H.

Volltext

Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption von Lammert, Craig, Chalasani, Sai N., Green, Kelsey, Atkinson, Elizabeth, McCauley, Bryan, Lazaridis, Konstantinos N.

Volltext

The diagnostic accuracy of vibration controlled transient elastography for cirrhosis in subjects with nonalcoholic fatty liver disease von Siddiqui, M.S, Vuppulanchi, R, Van Natta, M, Brandman, D, Tonascia, J.T, Chalasani, N, Middleton, M.S, Sanyal, A.J

Volltext

Environmental risk factors are associated with autoimmune hepatitis von Lammert, Craig, Chalasani, Sai N., Atkinson, Elizabeth J., McCauley, Bryan M., Lazaridis, Konstantinos N.

Volltext

LP15 : Separate and combined effects of obeticholic acid and weight loss in nonalcoholic steatohepatitis (NASH) von Hameed, B, Terrault, N, Gill, R, Loomba, R, Chalasani, N, Hoofnagle, J.H, Van Natta, M.L

Volltext

P1131 : Autoimmune hepatitis-like drug induced liver injury von de Boer, Y.S, Kosinski, A.S, Urban, T.J, Zhao, Z, Long, N, Chalasani, N, Hoofnagle, J.H

Volltext

1332 SERUM HEPCIDIN LEVELS IN THE MORBIDLY OBESE PATIENTS UNDERGOING BARIATRIC SURGERY von Vuppalanchi, R, Konrad, R, Chalasani, N

Volltext

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterol... von Chalasani, Naga, Younossi, Zobair, Lavine, Joel E., Diehl, Anna Mae, Brunt, Elizabeth M., Cusi, Kenneth, Charlton, Michael, Sanyal, Arun J.

Volltext

Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort von Church, Rachel J., Kullak‐Ublick, Gerd A., Aubrecht, Jiri, Bonkovsky, Herbert L., Chalasani, Naga, Fontana, Robert J., Goepfert, Jens C., Hackman, Frances, King, Nicholas M. P., Kirby, Simon, Kirby, Patrick, Marcinak, John, Ormarsdottir, Sif, Schomaker, Shelli J., Schuppe‐Koistinen, Ina, Wolenski, Francis, Arber, Nadir, Merz, Michael, Sauer, John‐Michael, Andrade, Raul J., van Bömmel, Florian, Poynard, Thierry, Watkins, Paul B.

Volltext

Benchmarking of Container Analysis Fire Environment simulation using the memorial tunnel fire ventilation tests von Chalasani, N., Greiner, M., Suo-Anttila, A.

Volltext

Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts von Chalasani, Naga, Gorski, J.Christopher, Patel, Nilesh H., Hall, Stephen D., Galinsky, Raymond E.

Volltext

72 MAPPING EXPRESSION QUANTITATIVE TRAITS LOCI (eQTL) FOR PNPLA3 GENE IDENTIFIES ADDITIONAL SNPS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) INDEPENDENT OF rs738409 von Wang, X, Onjiko, R.M, Anstee, Q.M, Ratziu, V, Liu, Y.-L, Cordell, H.J, Darlay, R, Day, C.P, Daly, A.K, Chalasani, N, Liu, W

Volltext

Inhibition of Human Intestinal Wall Metabolism by Macrolide Antibiotics: Effect of Clarithromycin on Cytochrome P450 3A4/5 Activity and Expression von Pinto, Amar G., Wang, Ying‐Hong, Chalasani, Naga, Skaar, Todd, Kolwankar, Dhanashri, Gorski, J. Christopher, Liangpunsakul, Suthat, Hamman, Mitchell A., Arefayene, Million, Hall, Stephen D.

Volltext

104 A CANDIDATE-GENE APPROACH TO VALIDATION OF GENETIC MODIFIER ASSOCIATIONS USING A LARGE COHORT WITH HISTOLOGICALLY CHARACTERISED NON-ALCOHOLIC FATTY LIVER DISEASE von Anstee, Q.M, Darlay, R, Leathart, J, Liu, Y.-L, Tordjman, J, Clement, K, Aithal, G, Valenti, L, Van Gaal, L, Stickel, F, Alison, M, Romero-Gomez, M, Andrade, R, Reeves, H, Bedossa, P, Pihlajamaki, J, Kotronen, A, Yki-Jarvinen, H, Chalasani, N, Kleiner, D.E, Rotter, J, Burt, A, Ratziu, V, Cordell, H.J, Daly, A.K, Day, C.P

Volltext